Cronos Group is a Canadian manufacturer of canabis. It operates as a diversified and vertically integrated company. The company offers platforms for the production and distribution of medical marijuana, and cultivates cannabis oil. Cronos Group serves customers in Canada.
P/E
Net profit
P/B
Book value
P/FCF
FCF
Yield
Growth potential
Cronos Group news
10.05.2022
Cronos Group's GAAP loss for 3 months of 2022 was $32.653 million, down 4.9 times from $161.625 million in the previous year. Revenue increased 98.5% to $25.033 million compared to $12.611 million a year earlier.
Source: 
thecronosgroup.gcs-web.com
thecronosgroup.gcs-web.com
01.03.2022
Cronos Group's GAAP loss for 2021 was $397.204 million, up 5.27 times from $75.27 million in the previous year. Revenue increased 59.3% to $74.435 million from $46.719 million a year earlier.
Source: thecronosgroup.gcs-web.com
thecronosgroup.gcs-web.com
18.02.2022
Cronos Group's GAAP loss for 9 months of 2021 was $263.312 million, compared to a profit of $36.442 million in the previous year. Revenue increased 68.9% to $58.092 million from $34.397 million a year earlier.
Source: 
ir.thecronosgroup.com
ir.thecronosgroup.com
06.08.2021
Cronos Group's GAAP loss for six months of 2021 was $104.85 million, up 2.3 times from $32.022 million in the previous year. Revenue increased 61.3% to $33.502 million from $20.776 million a year earlier.
Source: thecronosgroup.gcs-web.com
thecronosgroup.gcs-web.com
General information
| Company name | Cronos Group |
|---|---|
| Tags | #pharmacy |
| Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals / Pharmaceuticals |
| Business address | 720 KING STREET W SUITE 320 TORONTO A6 M5V 2T3 (416) 504-0004 |
| Mailing address | 720 KING STREET W SUITE 320 TORONTO A6 M5V 2T3 |
| Website | thecronosgroup.com |
| Information disclosure | www.sec.gov |
English (US) 